Reba Hsu is currently working as an Adherence Rater at MAPS Public Benefit Corporation, reviewing recordings of therapy sessions for MDMA-assisted therapy clinical trials. Reba is also an Inpatient Hospice Social Worker at By The Bay Health, providing end-of-life care to patients. Reba previously worked as a Project Associate at Civity and a Film Distribution Coordinator at Skoll Foundation. Reba has a background in social work and a Master of Social Work from Columbia University.
Lykos Therapeutics (formerly MAPS PBC)
At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com.